Korean Drug Co Ltd banner
K

Korean Drug Co Ltd
KOSDAQ:014570

Watchlist Manager
Korean Drug Co Ltd
KOSDAQ:014570
Watchlist
Price: 4 040 KRW -0.49% Market Closed
Market Cap: ₩44.4B

Balance Sheet

Balance Sheet Decomposition
Korean Drug Co Ltd

Balance Sheet
Korean Drug Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
1 701
1 273
969
1 360
2 047
1 455
1 951
1 853
1 446
1 568
2 099
2 338
3 256
3 268
3 219
3 146
2 397
5 480
6 270
7 068
4 841
3 426
11 689
4 103
Cash
0
0
0
0
0
0
0
0
0
0
0
1 237
1 282
934
0
0
0
0
165
163
165
182
115
38
Cash Equivalents
1 701
1 273
969
1 360
2 047
1 455
1 951
1 853
1 446
1 568
2 099
1 101
1 974
2 334
3 219
3 146
2 397
5 480
6 105
6 905
4 677
3 244
11 574
4 066
Short-Term Investments
140
784
932
534
731
577
622
40
51
46
41
30
16
5
350
848
753
3 141
5 255
15 162
23 039
22 990
5 067
14 897
Total Receivables
18 528
21 356
22 658
23 299
25 030
25 162
26 855
27 801
30 360
36 805
38 261
36 207
32 362
31 007
26 659
32 334
36 099
32 891
28 080
27 894
28 983
31 460
28 008
22 891
Accounts Receivables
18 329
21 225
22 480
23 201
24 958
24 962
26 736
27 681
30 277
36 709
38 078
36 110
32 300
30 985
26 640
32 317
36 059
32 877
28 040
27 880
28 501
31 196
27 854
22 813
Other Receivables
199
131
178
98
72
200
119
120
83
96
183
97
62
22
19
17
40
14
40
14
482
264
154
78
Inventory
3 592
3 340
3 422
3 466
3 383
4 164
4 528
5 797
6 454
7 737
7 206
8 554
8 823
9 540
9 918
8 318
9 074
9 383
11 839
10 744
12 894
13 775
18 341
20 168
Other Current Assets
66
119
50
56
689
692
836
652
831
207
197
394
135
128
290
276
408
39
90
2 087
693
965
321
867
Total Current Assets
24 028
26 871
28 031
28 716
31 881
32 051
34 792
36 143
39 142
46 363
47 804
47 524
44 591
43 947
40 437
44 922
48 730
50 935
51 535
62 956
70 450
72 617
63 426
62 925
PP&E Net
13 023
12 762
13 372
12 844
12 481
12 661
13 203
13 736
15 049
16 479
16 399
16 144
15 580
15 223
14 919
14 565
14 878
12 630
14 849
13 784
13 999
18 607
22 999
22 054
PP&E Gross
13 023
12 762
13 372
12 844
12 481
12 661
13 203
13 736
15 049
16 479
16 399
16 144
15 580
15 223
0
0
0
12 630
14 849
13 784
13 999
18 607
22 999
22 054
Accumulated Depreciation
2 765
3 540
4 396
5 214
5 891
6 493
7 338
8 242
8 955
8 647
9 665
10 554
11 467
12 362
0
0
0
15 584
16 356
17 566
18 291
19 158
19 934
21 558
Intangible Assets
504
256
63
29
31
29
22
29
84
653
647
311
294
757
892
796
834
758
661
684
274
502
374
220
Note Receivable
183
190
189
222
206
181
285
577
622
481
561
0
0
0
1 163
837
715
0
0
0
0
0
0
0
Long-Term Investments
289
166
159
199
34
62
682
682
952
1 247
1 247
1 283
1 283
860
1 219
1 694
706
5 429
5 514
3 402
2 140
1 303
1 040
1 296
Other Long-Term Assets
0
0
0
0
0
0
0
197
160
133
24
680
1 793
1 387
567
597
930
3 210
3 291
2 519
1 749
1 488
1 870
2 393
Total Assets
38 028
N/A
40 246
+6%
41 814
+4%
42 008
+0%
44 632
+6%
44 983
+1%
48 983
+9%
51 363
+5%
56 009
+9%
65 356
+17%
66 682
+2%
65 943
-1%
63 542
-4%
62 175
-2%
59 197
-5%
63 411
+7%
66 794
+5%
72 962
+9%
75 850
+4%
83 345
+10%
88 613
+6%
94 516
+7%
89 709
-5%
88 887
-1%
Liabilities
Accounts Payable
1 352
1 041
1 697
1 556
1 834
1 923
1 656
1 493
2 111
2 511
2 490
2 882
2 245
2 649
3 247
4 750
4 347
2 663
3 066
2 662
3 213
5
1 921
570
Accrued Liabilities
346
655
584
619
801
753
926
813
759
1 161
1 063
967
1 205
1 041
0
0
0
1 759
1 843
1 934
2 313
2 869
2 768
2 856
Short-Term Debt
9 200
9 200
9 200
8 700
8 000
6 000
5 500
7 049
9 386
12 224
10 600
10 500
7 000
4 000
1 000
500
500
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
75
56
0
0
0
0
0
0
0
0
0
0
0
500
1 500
0
500
0
54
46
39
59
51
63
Other Current Liabilities
1 114
1 004
396
807
1 151
919
1 798
677
299
914
727
266
460
1 116
1 560
2 784
3 255
2 139
1 560
5 130
4 764
4 479
5 162
3 721
Total Current Liabilities
12 087
11 956
11 877
11 681
11 786
9 595
9 880
10 032
12 555
16 810
14 880
14 614
10 909
9 307
7 308
8 034
8 602
6 561
6 523
9 771
10 329
7 412
9 902
7 210
Long-Term Debt
56
0
0
0
0
0
0
0
0
2 000
2 000
1 000
3 000
2 000
500
500
0
0
26
6
15
22
16
18
Deferred Income Tax
651
687
664
63
330
174
104
0
0
208
234
134
216
110
145
0
0
237
11
0
0
0
0
0
Other Liabilities
1 791
1 754
1 654
2 177
1 985
2 217
2 494
2 356
2 350
2 095
2 598
2 620
1 994
1 967
1 567
1 216
1 218
3 364
4 240
2 697
1 579
2 370
2 701
3 553
Total Liabilities
14 585
N/A
14 397
-1%
14 195
-1%
13 921
-2%
14 101
+1%
11 987
-15%
12 478
+4%
12 388
-1%
14 905
+20%
21 112
+42%
19 712
-7%
18 368
-7%
16 119
-12%
13 384
-17%
9 519
-29%
9 749
+2%
9 821
+1%
10 163
+3%
10 800
+6%
12 474
+16%
11 923
-4%
9 804
-18%
12 619
+29%
10 781
-15%
Equity
Common Stock
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
5 500
Retained Earnings
11 562
13 968
15 695
16 182
18 619
21 091
24 567
27 091
29 219
35 338
38 064
38 668
38 687
40 089
41 025
45 087
48 456
54 307
56 636
62 488
69 345
77 364
69 724
70 591
Additional Paid In Capital
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 407
3 154
3 049
3 057
3 407
3 407
3 407
3 407
3 407
3 407
3 407
Unrealized Security Profit/Loss
3 512
3 512
3 556
3 537
3 544
3 536
3 569
3 512
3 512
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
170
205
0
0
0
419
499
536
1 586
1 583
1 563
1 360
Other Equity
538
538
538
538
538
538
538
534
534
0
0
0
0
0
0
26
40
5
7
12
24
24
23
32
Total Equity
23 442
N/A
25 849
+10%
27 619
+7%
28 088
+2%
30 531
+9%
32 997
+8%
36 505
+11%
38 975
+7%
41 104
+5%
44 245
+8%
46 970
+6%
47 575
+1%
47 423
0%
48 791
+3%
49 679
+2%
53 662
+8%
56 973
+6%
62 799
+10%
65 050
+4%
70 871
+9%
76 690
+8%
84 713
+10%
77 090
-9%
78 106
+1%
Total Liabilities & Equity
38 028
N/A
40 246
+6%
41 814
+4%
42 008
+0%
44 632
+6%
44 983
+1%
48 983
+9%
51 363
+5%
56 009
+9%
65 356
+17%
66 682
+2%
65 943
-1%
63 542
-4%
62 175
-2%
59 197
-5%
63 411
+7%
66 794
+5%
72 962
+9%
75 850
+4%
83 345
+10%
88 613
+6%
94 516
+7%
89 709
-5%
88 887
-1%
Shares Outstanding
Common Shares Outstanding
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11